Ironwood Pharmaceuticals (IRWD) Earnings
|
Expand Research on IRWD
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +5.5% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -1.6% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 8/4/22 | Q222 | N/A | $0.34 | N/A | N/A | $103.91M | N/A | N/A | N/A | ||
| 5/5/22 |  |
Q122 | $0.21 | $0.25 | -$0.04 | $98M | $93.97M | N/A |  | | Details |
| 2/17/22 | |
Q421 | $0.27 | $0.35 | -$0.08 | $117.13M | $109.87M | N/A | | | Details |
| 11/4/21 | |
Q321 | $0.33 | $0.31 | +$0.02 | $103.8M | $105.4M | N/A | | | Details |
| 8/5/21 | |
Q221 | $0.34 | $0.22 | +$0.12 | $104.1M | $93.1M | N/A | | | Details |
| 5/6/21 | |
Q121 | $0.24 | $0.21 | +$0.03 | $88.85M | $95.2M | N/A | | | Details |
| 2/17/21 | |
Q420 | $0.36 | $0.29 | +$0.07 | $116.7M | $111.95M | N/A | | | Details |
11/5/20  |
|
Q320 | N/A | $0.15 | N/A | N/A | $95.96M | N/A | N/A | N/A |
